Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Receivables - Net (2023 - 2025)

Historic Receivables - Net for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $5.1 million.

  • Zhengye Biotechnology Holding's Receivables - Net changed N/A to $5.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $10.5 million for FY2024, which is 2023.69% down from last year.
  • According to the latest figures from Q2 2025, Zhengye Biotechnology Holding's Receivables - Net is $5.1 million.
  • Zhengye Biotechnology Holding's 5-year Receivables - Net high stood at $12.9 million for Q4 2023, and its period low was $5.1 million during Q2 2025.
  • Over the past 3 years, Zhengye Biotechnology Holding's median Receivables - Net value was $8.3 million (recorded in 2024), while the average stood at $8.8 million.
  • Examining YoY changes over the last 5 years, Zhengye Biotechnology Holding's Receivables - Net showed a top increase of 3565.15% in 2024 and a maximum decrease of 3565.15% in 2024.
  • Over the past 3 years, Zhengye Biotechnology Holding's Receivables - Net (Quarter) stood at $12.9 million in 2023, then crashed by 35.65% to $8.3 million in 2024, then plummeted by 38.41% to $5.1 million in 2025.
  • Its Receivables - Net stands at $5.1 million for Q2 2025, versus $8.3 million for Q4 2024 and $12.9 million for Q4 2023.